The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
09/29/2012
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Description of Modification
This Prgram Announcement is modified only to extend the Pre-application deadline from November 5, 2012 to November 13, 2012. No other changes have been made.
Document Type:
Modification to Previous
Grants Notice
Funding Opportunity Number:
W81XWH-12-MRPRA-MRFA
Opportunity Category:
Discretionary
Posted Date:
Sep 29, 2012
Creation Date:
Nov 03, 2012
Original Closing Date for Applications:
Feb 04, 2013
Current Closing Date for Applications:
Feb 04, 2013
Archive Date:
Mar 06, 2013
Funding Instrument Type:
Cooperative Agreement
Grant
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
1
Estimated Total Program Funding:
$6,400,000
Award Ceiling:
$6,400,000
Award Floor:
$0
CFDA Number(s):
12.420
--
Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
Dept. of the Army -- USAMRAA
Description
Applications to the FY12 Militarily Relevant Peer Reviewed Alzheimer’s Disease ResearchProgram (MRPRA) are being solicited for the Assistant Secretary of Defense for Health Affairs,Defense Health Program Medical Research and Development Office by the UnitedStates Army Medical Research Acquisitions Activity (USAMRAA). The Telemedicine andAdvanced Technology Research Center (TATRC) is administering the application process, andUSAMRAA is issuing this Program Announcement and will be negotiating all resulting awards.Military personnel who suffer severe or moderate TBI face an increased risk for developingseveral long-term health problems. These conditions include Alzheimer's-like dementia,aggression, memory loss, depression, and symptoms similar to those of other neurologicaldiseases. Even mild TBI may be associated with some of these adverse consequences.The mission of the MRPRA is to build an integrated program devoted towards understanding the association between Traumatic Brain Injury (TBI) and Alzheimer’s disease (AD), and reducingthe burden on those affected especially in the military community. Therefore, the primaryobjective of the FY12 MRPRA is to facilitate the development of research tools and clinicaloutcomes that will permit the detection and diagnosis of neurological change found with TBI associated AD. A second, but equally important, objective for the FY12 MRPRA is the development of technologies intended to directly benefit individuals suffering from the symptoms of neurological impairment associated with either TBI or AD. Research falling under this second objective is intended to either increase or maintain the quality of life of those affectedby the symptoms of either TBI or AD. Research funded through the Military Risk Factors Research Award (MRFA) Program Announcement/Funding Opportunity is intended to facilitate high-impact, systematic, population-based, research into the association between TBI and AD. The research impact is intended to benefit the military community, while meeting a public purpose for the benefit of the civilian community. Applications must detail the plan for providing access to the study cohort. Preliminary data which supports how the cohort will be used in the study is also required. The preliminary data should also strongly support the proposed research hypotheses.
Link to Additional Information
If you have difficulty accessing the full announcement
electronically, please contact:
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.
